SELLA, STEFANIA
 Distribuzione geografica
Continente #
NA - Nord America 3.042
EU - Europa 507
AS - Asia 265
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Totale 3.822
Nazione #
US - Stati Uniti d'America 3.040
CN - Cina 261
IT - Italia 160
DE - Germania 100
FI - Finlandia 90
UA - Ucraina 62
SE - Svezia 39
GB - Regno Unito 28
FR - Francia 14
IE - Irlanda 5
NZ - Nuova Zelanda 4
RU - Federazione Russa 4
AT - Austria 3
IN - India 3
BR - Brasile 2
CA - Canada 2
AU - Australia 1
BE - Belgio 1
HK - Hong Kong 1
NL - Olanda 1
SC - Seychelles 1
Totale 3.822
Città #
Fairfield 475
Chandler 289
Jacksonville 276
Ashburn 255
Woodbridge 240
Houston 231
Wilmington 187
Seattle 185
Cambridge 174
Ann Arbor 153
Princeton 95
Beijing 80
Medford 66
San Diego 48
Des Moines 43
Nanjing 37
Helsinki 31
Padova 31
Guangzhou 27
Boardman 25
Roxbury 20
Shenyang 16
Hebei 12
Jiaxing 12
Nanchang 12
Norwalk 11
Capannoli 10
Hefei 9
Milan 9
Washington 9
Jinan 7
Cagliari 6
Kunming 6
Zhengzhou 6
Changsha 5
Dublin 5
Ogden 5
Philadelphia 5
Tianjin 5
Bologna 4
Brescia 4
Kilburn 4
London 4
Selvazzano Dentro 4
Dearborn 3
Modena 3
Ningbo 3
Orange 3
Redwood City 3
Furci Siculo 2
Hangzhou 2
Múggia 2
New Bedfont 2
New York 2
Pinehaven 2
Ponte Di Piave 2
Quarto d'Altino 2
Rockville 2
Spinea 2
Taiyuan 2
Vienna 2
Acton 1
Alto Longa 1
Americana 1
Atlanta 1
Auckland 1
Borås 1
Brendola 1
Brisbane 1
Brussels 1
Buttrio 1
Carcare 1
Castiglione Delle Stiviere 1
Catania 1
Chaoyang 1
Chengdu 1
Chicago 1
Dallas 1
Delhi 1
Edinburgh 1
Ercolano 1
Esslingen am Neckar 1
Ferentino 1
Ferrara 1
Fuzhou 1
Haikou 1
Hyderabad 1
Islington 1
Lachine 1
Lanzhou 1
Lappeenranta 1
Las Vegas 1
Los Angeles 1
Mahé 1
Mirano 1
Molise 1
Monselice 1
Noisy-le-grand 1
Old Bridge 1
Pisa 1
Totale 3.216
Nome #
Low vitamin K1 intake in haemodialysis patients 185
Vitamin K plasma levels determination in human health 168
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins 165
Fast method for skeletal tissue gene expression analysis 130
Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus 130
Cigarette smoking is associated with decreased Bone Gla-protein (BGP) levels in hemodialysis patients. 121
Use of antiosteoporotic drugs and calcium/vitamin D in patients with fragility fractures: impact on re-fracture and mortality risk 110
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011 104
Bone disease in primary hypercalciuria 103
The relationship between the Spine Deformity Index, biochemical parameters of bone metabolism and vascular calcifications: results from the Epidemiological VERtebral FRACtures iTalian Study (EVERFRACT) in dialysis patients. 100
Osteoporosi associata a calciuria idiopatica: una forma peculiare di osteopatia metabolica 84
Bone disease in primary hypercalciuria 78
Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis 74
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 74
Persistent Secondary Hyperparathyroidism and Vertebral Fractures in Kidney Transplantation: Role of Calcium-Sensing Receptor Polymorphisms and Vitamin D Deficiency 72
Efficacy of weekly administration of cholecalciferol on parathyroid hormone in stable kidney-transplanted patients with CKD stage 1-3. 71
Osteoporosi nel paziente sottoposto a trapianto d'organo. 66
Histomorphometric analysis of glucocorticoid-induced osteoporosis. 64
Risk factors for hip fracture in elderly persons. 63
Effectiveness of In-Hospital Cholecalciferol Use on Clinical Outcomes in Comorbid COVID-19 Patients: A Hypothesis-Generating Study 63
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 61
Persistent secondary hyperparathyroidism after renal transplantation: effects of therapy with cholecalciferol 59
Hypovitaminosis D in a acute ward of internal medicine 57
Densitometric threshold and vertebral fractures in heart transplant patients. 57
Osteoporosi nel paziente sottoposto a trapianto d'organo 55
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 55
Overweight - obesity is associated with decreased vitamin K2 levels in hemodialysis patients 54
Osteoporosis associated with idiopathic hypercalciuria: A peculiar form of metabolic bone disease. 52
Vitamin K and Osteoporosis 50
Osteoporosis associated with idiopathic hypercalciuria: a peculiar form of metabolic osteopathy. 49
Frequenza ed importanza dell'ipercalciuria idiopatica nelle donne in menopausa con ridotta massa ossea. 47
Bisfosfonati e osteoporosi da trapianto 46
Bisfosfonati e osteodistrofia renale 45
Evaluation of cell apoptosis and Cox-2 expression in glucocorticoid-induced osteoporosis in rats treated with risedronate 44
Iperparatiroidismo secondario persistente dopo trapianto di rene e ruolo causale dell’ipovitaminosi D. 44
Bisfosfonati per via parenterale 43
Prescrizione di farmaci e fratture da fragilità. 40
Osteopenia indotta da farmaci immunodepressivi: dati preliminari sull'effetto del risedronato 40
Polimorfismo del recettore della vitamina D (VDR) ed iperparatiroidismo persistente (IP) nel trapianto di rene 38
Aspetti clinici della terapia dell'osteoporosi con ibandronato. L'ibandronato: dall'efficacia alla pratica clinica. 37
Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study 37
POLIMORFISMO DEL RECETTORE DELLA VIT D ED IPERPARATIROIDISMO PERSISTENTE NEL TRAPIANTO DI RENE 36
Iperparatiroidismo secondario persistente dopo trapianto di rene: fattori eziopatogenici e possibili correzioni 36
Osteopenia induced by immunosuppressive drugs: Preliminary data on risedronate effect. 35
Frequenza ed importanza dell’ipercalciuria idiopatica nelle donne in menopausa con ridotta massa ossea 35
Prevalenza e significato clinico dell’ipovitaminosi D in una divisione di medicina interna per acuti. 35
The line between COVID-19 pandemic and rare bone diseases 34
Vitamin K and kidney transplantation 33
Osteoporosis associated with idiopathic hypercalciuria: a peculiar form of metabolic bone disease 32
Osteoporosi maschile 32
The initiative on hip fractures of the Veneto Region 32
Oral Calcitriol Use, Vertebral Fractures, and Vitamin K in Hemodialysis Patients: A Cross-Sectional Study 32
Valutazione dell’apoptosi cellulare e dell’espressione della COX-2 nell’osteoporosi indotta da glucocorticoidi in ratti trattati con risedronato. 29
Bone metabolism in primary hypercalciuria 28
Un caso di osteosclerosi associata a HCV: effetti della terapia antivirale. 28
Perspective on the clinical practice management of hypovitaminosis D from a meeting of Italian experts 28
Osteoporosi associata ad ipercalciuria idiopatica: una forma peculiare di osteopatia metabolica. 27
Iperparatiroidismo secondario persistente dopo trapianto di rene: effetti della terapia con colecalciferolo. 23
Ipovitaminosi D in una divisione di Medicina Interna per acuti. 23
Iperparatiroidismo secondario persistente dopo trapianto di rene: effetti scheletrici. 22
The vessels‐bone axis: Iliac artery calcifications, vertebral fractures and vitamin k from viki study 22
The Potential Impact of Inducing a Restriction in Reimbursement Criteria on Vitamin D Supplementation in Osteoporotic Patients with or without Fractures 20
Iperparatiroidismo secondario persistente dopo trapianto di rene: ruolo del CaSR e dell’ipovitaminosi D. 20
Osteopenia indotta da farmaci immunosoppressivi: dati preliminari sull'effetto del risedronato. 20
Osteoporosis in heart-transplant recipients: Preliminary data of a multicenter study. 20
Polimorfismo del recettore della vitamina D (VDR) ed iperparatiroidismo persistente (IP) nel trapianto di rene. 19
Economic Burden of Osteoporotic Patients with Fracture: Effect of Treatment With or Without Calcium/Vitamin D Supplements 17
Iperparatiroidismo secondario persistente dopo trapianto di rene: ruolo dell’ipovitaminosi D ed effetti della terapia. 16
Efficacia del neridronato nel trattamento di pazienti trapiantati d'organo con fragilita' ossea 15
Iperparatiroidismo secondario persistente dopo trapianto di rene e ruolo causale dell’ipovitaminosi D 15
Bisfosfonati per via parenterale 14
Osteoporosi:la sfida della gestione della cronicità alla luce dei recenti progressi terapeutici 14
Stem cells transplantation into an animal model of glucocorticoid-induced bone damage 9
Stem cells transplantation into an animal model of glucocorticoid-induced bone damage 9
Incidenza di frattura di femore nella Regione Veneto negli anni 2000-2011 8
Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series 8
Impact of implementing a Choosing Wisely educational intervention into clinical practice: The CW-SIMI study (a multicenter-controlled study) 7
Hepatitis C-associated Osteosclerosis (HCAO): Long-Term Follow-Up of a New Case Recovered After Antiviral Treatment 5
Tubular phosphate transport: a comparison between different methods of urine sample collection in FGF23-dependent hypophosphatemic syndromes 4
Evaluating benefit from vitamin D supplementation: defining the area for treatment 4
Totale 3.881
Categoria #
all - tutte 13.485
article - articoli 10.328
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 139
patent - brevetti 0
selected - selezionate 0
volume - volumi 627
Totale 24.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019276 0 0 0 0 0 0 0 0 0 81 94 101
2019/2020829 129 46 9 49 75 59 96 89 103 94 41 39
2020/2021762 31 38 23 47 34 84 9 61 126 168 91 50
2021/2022677 39 110 49 55 41 31 29 67 24 15 60 157
2022/2023589 176 57 8 85 94 60 2 35 46 2 21 3
2023/2024252 14 40 28 27 34 43 24 25 9 8 0 0
Totale 3.881